Title for MeetingAbstracts
Alphabetical listing of titles
-
Final Analysis of a Randomised Trial to Evaluate Safety and Efficacy of Indinavir/Ritonavir versus Saquinavir/Ritonavir in Adult HIV-1 Infection: The MaxCmin1 Trial.
-
Final analysis of ritonavir (RTV) intensification in indinavir (IDV) recipients with detectable HIV RNA levels.
-
Final Analysis of T1249-102: T-1249 Retains Potent Short Term Antiviral Activity in Patients who Have Failed a Regimen Containing Enfuvirtide (ENF).
-
Final diagnosis in patients with negative broncho-alveolar lavage for pneumocystis.
-
Final planning: funeral, memorial, and other decisions.
-
Final report about AIDS/HIV knowledge in north west Argentinian indigenous women.
-
Final report of a randomized phase II study of GLQ223 in AIDS and ARC.
-
Final report on longterm followup of symptomatic HIV+ patients randomized to early vs later zidovudine (ZDV) Rx.
-
Final Report on The Treatment of Severe Community Acquired Pneumonia in Elderly Patients.
-
Final results from a randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of CMV retinal and gastrointestinal mucosal disease.
-
Final Results of A Phase I Study of a Therapeutic Vaccine Using Autologous Dendritic Cells Primed with Autologous Virus in Patients with Chronic HIV Infection and CD4 T Cells above 400/Mm3.
-
Final results of a two year, multiple opportunistic pathogen prophylaxis study (MOPPS) persons with CD4 < 200/mm3.
-
Final results of ANRS HC02 - RIBAVIC: A randomized controlled trial of pegylated-interferon alfa-2b plus ribavirin vs interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-infected patients.
-
Final Results of ANRS HC02-RIBAVIC: A Randomized Controlled Trial of Pegylated-Interferon-alfa-2b plus Ribavirin vs Interferon-alfa-2b plus Ribavirin for the Initial Treatment of Chronic Hepatitis C in HIV Co-infected Patients.
-
Final Results of APRICOT: A Randomized, Partially Blinded, International Trial Evaluating Peginterferon-alfa-2a + Ribavirin vs Interferon-alfa-2a + Ribavirin in the Treatment of HCV in HIV/HCV Co-infection.
-
Final Results of Daily vs 3-times Weekly Interferon alpha-2b plus Ribavirin for the Treatment of Hepatitis C Infection in HIV-infected Persons: A Multi-center, Randomized Open-label Study.
-
Final Week 48 Analysis of a Phase 4, Randomised, Open-label, Multi-center Trial to Evaluate Safety and Efficacy of Continued Lamivudine Twice Daily Versus Discontinuation of Lamivudine in HIV-1-infected Adults with Virological Failure on Ongoing Combination Treatments Containing Lamivudine: The COLATE Trial.
-
Final year medical students and HIV testing.
-
Finance for health: An Impact assessment of Kenya voluntary women rehabilitation centre's (KVOWRC) support programme for commercial sex workers (CSWS).
-
Financial access to care among chronically ill HMO populations: do differences in copayment amounts explain care differences previously attributed to race?.
-
Financial access to HIV/AIDS health services in Kenya; Findings from National health accounts.
-
Financial and Organisational Barriers to Integrated Care: an International Comparison.
-
Financial and Organizational Factors Affecting the Employment of Nurse Practitioners and Physician Assistants in Medical Group Practices.
-
Financial Barriers to Prescription Medication Use Among the Elderly.
-
Financial constraints and guiding principles in managing PMTCT services in western rural Kenya.
-
Financial control systems in radiology - The Swedish experience.
-
Financial Impact of Prospective Payment System on Rural Home Health Agencies in the United States.
-
Financial Incentive Effects on Physician Behavior: Organization-Level and Individual Tiers.
-
Financial Incentive Effects on Physician Behavior: Organization-Level and Individual Tiers.
-
Financial Incentives and Gaming in Alcohol Treatment.